We observed that APS could increase the activity of NO and NOS and reduce ET-1 to protect vascular endothelium, in addition to inhibiting the release of inflammatory mediators, improving endothelial injury and maintaining the balance of vasomotor function (Figures 3(a)–3(f)). Here, EDN1 is linked to autoimmune polyendocrinopathy.